Rhenman & Partners Asset Management AB / ABT
Rhenman & Partners Asset Management AB’s Abbott Laboratories Position
Does Rhenman & Partners Asset Management AB own Abbott Laboratories (ABT)? Yes — 112.0K shares worth $11M (+1.42% of its 13F portfolio) as of Q1 2026, up from 98.5K shares the prior filed quarter.
Position Value
$11M
Q1 2026
Shares
112.0K
% of Portfolio
+1.42%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 112.0K | $11M | +1.42% |
| Q3 2025 | 98.5K | $13M | +1.46% |
| Q2 2025 | 58.5K | $8M | +1.01% |
| Q1 2025 | 52.0K | $7M | +0.79% |
| Q4 2024 | 128.0K | $14M | +1.49% |
| Q3 2024 | 135.0K | $15M | +1.25% |
| Q2 2024 | 145.0K | $15M | +1.45% |
| Q1 2024 | 185.0K | $21M | +1.99% |
| Q4 2023 | 205.0K | $23M | +2.25% |
| Q3 2023 | 261.7K | $25M | +2.73% |
| Q2 2023 | 249.0K | $27M | +2.86% |
| Q1 2023 | 185.0K | $18M | +2.01% |
| Q4 2022 | 117.0K | $13M | +1.34% |
| Q3 2022 | 117.0K | $12M | +1.21% |
| Q2 2022 | 170.0K | $18M | +2.10% |
| Q1 2022 | 90.0K | $11M | +1.05% |
| Q4 2021 | 100.0K | $14M | +0.94% |
| Q3 2021 | 206.0K | $24M | +1.71% |
| Q2 2021 | 250.0K | $29M | +1.97% |
| Q1 2021 | 275.0K | $33M | +2.30% |
| Q4 2020 | 150.0K | $16M | +1.34% |
| Q3 2020 | 205.0K | $22M | +1.98% |
| Q2 2020 | 185.0K | $17M | +1.83% |
| Q1 2020 | 170.0K | $13M | +1.88% |
| Q4 2019 | 207.5K | $18M | +1.97% |
| Q3 2019 | 220.1K | $18M | +2.31% |
| Q2 2019 | 259.6K | $22M | +2.40% |
| Q1 2019 | 259.6K | $21M | +2.43% |
| Q4 2018 | 264.6K | $19M | +2.19% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of ABT.